Old Web
English
Sign In
Acemap
>
authorDetail
>
April M. Barbour
April M. Barbour
Merck & Co.
Medicine
Diabetes mellitus
Pharmacology
Pharmacokinetics
Dosing
3
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dosing Strategy for Itacitinib, a Selective JAK1 Inhibitor, for the Treatment of Ulcerative Colitis: 230
2019
The American Journal of Gastroenterology
April M. Barbour
Yan Zhang
Naresh Punwani
Sharon Diamond
Xuejun Chen
Swamy Yeleswaram
Show All
Source
Cite
Save
Citations (0)
Single Dose Euglycemic Clamp Studies Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between MK-1293 Insulin Glargine and Originator Insulin Glargine (Lantus) in Type 1 Diabetes and Healthy Subjects
2018
Diabetes, Obesity and Metabolism
Michael F. Crutchlow
John Palcza
Kate Mostoller
Chantal Mahon
April M. Barbour
Michael C. Marcos
Yang Xu
Elaine Watkins
Linda Morrow
Marcus Hompesch
Show All
Source
Cite
Save
Citations (10)
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy
2018
Clinical and Translational Science
Hwa-Ping Feng
Zifang Guo
Luzelena Caro
William L. Marshall
Fang Liu
Deborah Panebianco
Pavan Vaddady
April M. Barbour
Christina Reitmann
Patricia Jumes
Jocelyn Gilmartin
Dennis Wolford
Robert Valesky
Monika Martinho
Joan R. Butterton
Marian Iwamoto
Iain Fraser
Lynn Webster
Wendy W. Yeh
Show All
Source
Cite
Save
Citations (4)
1